Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) Recruiting

2022-502756-31-00 KRAS G12C-Mutant Advanced Solid Tumors 7 2022-07-20
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-C… Recruiting

2022-502646-27-00 Relapsed or Refractory Diffuse Large B-Cell Lymphoma 10 2022-06-24
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors. An open-label, multi-center, randomized phase III trial comparing safety a… Recruiting

2023-508572-11-00 neuroendocrine tumours 5 2022-06-21
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
ERIS: EGFR-Mutated Lung Cancer in Randomized Investigator-Initiated Study Recruiting

2024-518172-31-01 EGFR-mutated non-small cell lung cancer (NSCLC) not ame 5 2022-06-14
This study is to evaluate the safety and tolerability of Epcoritamab in Combination with Anti-Neoplastic Agents in Subjects with Non-Hodgkin… Recruiting

2023-505347-38-00 B-cell Non-Hodgkin's lymphoma, diffuse large B-cell lym 9 2022-06-13
A clinical study to learn about the safety and effects of KIN-2787, a new oral anticancer drug for the treatment of patients with BRAF and/o… Recruiting

2024-516331-27-00 Participants with BRAF and/or NRAS mutation positive tu 3 2022-06-10
Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting

2023-508852-21-00 Resectable, Early-stage (II to IIIB) Non-small Cell Lun 4 2022-06-10
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting

2023-503267-42-00 Patients with a histological diagnosis of mismatch- rep 5 2022-06-10
Trial of the novel peroral anti-tumor treatment in patients with solid tumors Recruiting

2024-511215-21-00 Metastatic or locally advanced solid tumors for which n 1 2022-06-07
Study of axitinib +/- pembrolizumab in first line treatment for patients with locally advanced or metastatic papillary renal cell carcinoma … Recruiting

2024-513986-38-00 Locally advanced or metastatic papillary cell carcinoma 4 2022-06-01
Sotorasib in advanced KRAS G12C-mutated non-small cell lung cancer patients with comorbidities (SOLUCOM) Recruiting

2023-503174-20-00 KRAS G12C-mutated non-small cell lung cancer 4 2022-05-30
A Phase 1/2 Study of BMS-986340 with and without Nivolumab or Docetaxel in Solid Tumors Recruiting

2023-503651-10-00 Male and female participants ≥ 18 years of age with adv 7 2022-05-17
Study evaluating the clinical impact of HDM201 + Pazopanib in patients with P53 wild-type advanced/ metastatic soft tissue sarcomas. Recruiting

2024-510706-86-00 Advanced/ metastatic soft tissue sarcomas 9 2022-05-16
Brigatinib in pediatric and young adult patients with ALK+ ALCL, IMT or other solid tumors (Briga-PED) Recruiting

2024-513412-10-00 Anaplastic Large Cell Lymphoma (ALCL) 9 2022-05-11
Study of the efficacy of intratumoral injections of L19IL2 + L19TNF followed by surgery to prevent or retard appearance of new metastases Recruiting

2023-507119-36-00 Malignant melanoma of the skin in patients with locally 5 2022-05-09
A phase II-III randomized trial evaluating maintenance pembrolizumab (± pemetrexed) until progression versus observation (± pemetrexed) afte… Recruiting

2024-515945-40-00 Non small cell lung cancer 10 2022-05-02
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Patients With Stage III Unresectabl… Recruiting

2023-506891-28-00 The target population of interest in this study is part 5 2022-05-02
Temozolomide and irinotecan consolidation in patients with MGMT silenced, microsatellite stable colorectal cancer with persistence of minima… Recruiting

2024-515681-14-00 Stage II (pT4)/III colorectal cancer with positive circ 4 2022-05-02
Clinical trial evaluating the safety, tolerability, and preliminary efficacy of BNT116 alone and in combinations in patients with advanced n… Recruiting

2023-509283-14-00 Advanced non-small cell lung cancer 1 2022-04-25
A Phase 1 First-in-Human Study of the Safety and Effects of VIR-5818 Alone or with Pembrolizumab in Participants with Advanced or Metastatic… Recruiting

2024-516010-38-00 Participants with Locally Advanced or Metastatic HER2-E 1 2022-04-25
The Effect of tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy – A randomized pilot… Recruiting

2024-515450-24-00 Epithelial ovarian cancer 4 2022-04-22
PEMBROCABOSARC : Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas Recruiting

2023-509496-16-00 Advanced /metastatic sarcomas: undifferentiated pleomor 4 2022-04-21
Nivolumab and ipilimumab in patients with dMMR and/or MSI metastatic colorectal cancer resistant to anti-PD1 monotherapy: An open-label phas… Recruiting

2024-516313-20-00 Metastatic colorectal cancer 4 2022-04-19